AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
- Bardia, A.
- Cortes, J.
- Hurvitz, S.A.
- Delaloge, S.
- Iwata, H.
- Shao, Z.-M.
- Kanagavel, D.
- Cohen, P.
- Liu, Q.
- Cartot-Cotton, S.
- Pelekanou, V.
- O’Shaughnessy, J.
Journal:
Therapeutic Advances in Medical Oncology
ISSN: 1758-8359, 1758-8340
Year of publication: 2022
Volume: 14
Type: Article